AstaThera Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A2

  • Investors
  • 7

AstaThera General Information

Description

Developer of radionuclide therapies and diagnostic and therapeutic radionuclide drugs intended for industry users and patients. The company focuses on the research and development of integrated diagnostic and therapeutic radionuclide drugs, using alpha radionuclide production and labeling technology, providing clients with a variety of innovative and effective treatments.

Contact Information

Website
www.astathera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 43
  • Number 136 Yuhai East Road, Hangzhou Bay New Area
  • Ningbo, Zhejiang 315336
  • China
+86 0574
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Oncology
Corporate Office
  • Building 43
  • Number 136 Yuhai East Road, Hangzhou Bay New Area
  • Ningbo, Zhejiang 315336
  • China
+86 0574

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstaThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A2) 14-Feb-2026 Completed Generating Revenue
3. Early Stage VC (Series A1) 29-Jul-2025 Completed Generating Revenue
2. Early Stage VC 06-May-2024 Completed Generating Revenue
1. Early Stage VC 18-Jul-2022 Completed Generating Revenue
To view AstaThera’s complete valuation and funding history, request access »

AstaThera Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Duce Capital Venture Capital Minority
Finnova Capital Venture Capital Minority
iHaier Accelerator/Incubator Minority
Hebei Coastal Industry Investment Fund Government Minority
Furong Capital Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

AstaThera Investments (1)

AstaThera’s most recent deal was a Joint Venture with Joint Venture (Alpha Nuclides / International Isotopes).

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Alpha Nuclides / International Isotopes) Joint Venture Medical Supplies
To view AstaThera’s complete investments history, request access »

Ready to get started?

Request a free trial

AstaThera FAQs

  • When was AstaThera founded?

    AstaThera was founded in 2020.

  • Where is AstaThera headquartered?

    AstaThera is headquartered in Ningbo, China.

  • What industry is AstaThera in?

    AstaThera’s primary industry is Drug Discovery.

  • Is AstaThera a private or public company?

    AstaThera is a Private company.

  • What is AstaThera’s current revenue?

    The current revenue for AstaThera is .

  • Who are AstaThera’s investors?

    Duce Capital, Finnova Capital, iHaier, Hebei Coastal Industry Investment Fund, and Furong Capital are 5 of 7 investors who have invested in AstaThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process